Product Information
AMLODIPINE BESYLATE 2.5 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0106 per EA under NDC 69097012615. Its NADAC has been published 586 times since Jul 15, 2015.
FDA first approved this application on Sep 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097012615
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA077073FDA Approved
9/26/2007
TE Code
AB
On Market Since
9/26/2007
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has been published 586 times since Jul 15, 2015, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0106 per EA |
|---|---|
| All-time high | $0.0227 (Oct 14, 2015) |
| All-time low | $0.0085 (Nov 20, 2024) |
| 52-week high | $0.0114 |
| 52-week low | $0.0102 |
| Median price | $0.0154 |
| Average price | $0.0150 |
| Largest weekly change | +34.0% (Aug 21, 2024) |
| Weeks tracked | 586 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
AMLODIPINE BESYLATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE BESYLATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 2.5 MG TAB, manufactured by Cipla USA Inc., is $0.0106 per EA (NDC 69097012615), effective Sep 30, 2026.
How has the price of AMLODIPINE BESYLATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has declined 50.0%. It has been tracked across 586 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 2.5 MG TAB?
Since Jul 15, 2015, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has ranged from a low of $0.0085 (Nov 20, 2024) to a high of $0.0227 (Oct 14, 2015), with a median of $0.0154 per EA.
Are there cheaper alternatives to AMLODIPINE BESYLATE 2.5 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0103 per EA — about 3% below AMLODIPINE BESYLATE 2.5 MG TAB.
Who manufactures AMLODIPINE BESYLATE 2.5 MG TAB?
AMLODIPINE BESYLATE 2.5 MG TAB (NDC 69097012615) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.